Back
Tekla Healthcare Opportunities Fund Vs. VanEck Pharmaceutical ETF Industry Stock Comparison
Sell
21
THQ
Tekla Healthcare Opportunities Fund
Last Price:
20.36
Seasonality Move:
0.53%
Buy
53
PPH
VanEck Pharmaceutical ETF
Last Price:
89.42
Seasonality Move:
5.66%
Sell
21
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $20.32. The Score for THQ is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
VanEck Pharmaceutical ETF (PPH)
is a Buy
Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?
- The current VanEck Pharmaceutical ETF [PPH] share price is $89.40. The Score for PPH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $20.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THQ is experiencing slight buying pressure.
PPH Stock Price Chart
What is VanEck Pharmaceutical ETF's stock price today?
-
The VanEck Pharmaceutical ETF share price today is $89.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 45.24 | Sell |
| Chaikin Money Flow: | 6480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.9 - 21.36) | Sell |
| Bollinger Bands (100): | (20.69 - 22.05) | Sell |
PPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.25 | Sell |
| Relative Strength Index (14 RSI): | 45.38 | Sell |
| Chaikin Money Flow: | 83373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.03 - 91.97) | Sell |
| Bollinger Bands (100): | (90.74 - 96.8) | Sell |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.76 | Buy |
| 20-day SMA: | 20.42 | Sell |
| 50-day SMA: | 21.33 | Sell |
| 200-day SMA: | 20.63 | Sell |
| 8-day EMA: | 20.06 | Buy |
| 20-day EMA: | 20.41 | Sell |
| 50-day EMA: | 20.95 | Sell |
| 200-day EMA: | 20.57 | Sell |
PPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.78 | Buy |
| 20-day SMA: | 89.35 | Buy |
| 50-day SMA: | 92.36 | Sell |
| 200-day SMA: | 91.62 | Sell |
| 8-day EMA: | 88.53 | Buy |
| 20-day EMA: | 89.45 | Sell |
| 50-day EMA: | 91.51 | Sell |
| 200-day EMA: | 90.72 | Sell |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
VanEck Pharmaceutical ETF Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||